Interpharm Holdings Inc. competitors

Zippia score 3.9

Competitor Summary. See how Interpharm Holdings Inc. compares to its main competitors:

Andrx Corp has the most employees (1,680).

Work at Interpharm Holdings Inc.?

Share your experience

Interpharm Holdings Inc. vs competitors

Company	Founding date	Zippia score	Headquarters	# of Locations	Revenue	Employees
Interpharm Holdings Inc.	-	3.9	Hauppauge, NY	1	-	670
Andrx Corp	1992	4.2	Davie, FL	1	-	1,680
Hi-Tech Pharmacal	1982	4.5	Amityville, NY	1	$232.4M	200
Eon Labs, Inc.	-	4.2	New York, NY	1	-	531
RedHill Biopharma	2009	4.1	Raleigh, NC	2	$64.4M	100
Pernix Therapeutics Holdings	1996	3.8	Morristown, NJ	1	$146.1M	171
Pharmaceutics International	1994	4.5	Huntingtown, MD	2	$367.8M	1,000
Mayne Pharma	-	4.1	Paramus, NJ	1	$780,000	10
LLS Health CDMO	1991	3.9	Bethlehem, PA	1	$910,000	1
Contract Pharmacal	1971	4.3	Hauppauge, NY	1	$54.0M	79
Mikart	1975	4.1	Atlanta, GA	1	$48.0M	3
Irvine Pharmaceutical Services	1988	4.3	Irvine, CA	1	$6.7M	100
Collegium Pharmaceutical	2002	4.4	Stoughton, MA	1	$310.0M	266
Novel Laboratories	2006	4.6	Somerset, NJ	1	$75.0M	93
Cambridge Major Laboratories, Inc.	-	3.5	Germantown, WI	1	$17.0M	200
Tergus Pharma	1994	4.1	Durham, NC	1	$11.6M	116
Upm Pharmaceuticals, Inc.	-	3.4	Bristol, TN	1	$460,000	25
URL Pharma	1946	4.4	Philadelphia, PA	1	$38.0M	211
Nostrum Laboratories	1995	4.0	Kansas City, MO	1	$15.0M	148
STASON PHARMACEUTICALS	1994	3.6	Irvine, CA	1	$1.2M	20
Sovereign Pharmaceuticals	1990	4.2	Fort Worth, TX	1	$52.7M	100

Rate Interpharm Holdings Inc.'s competitiveness in the market.

Interpharm Holdings Inc. salaries vs competitors

Compare Interpharm Holdings Inc. salaries vs competitors

Company	Average salary	Hourly salary	Salary score
Interpharm Holdings Inc.	$69,486	$33.41	-

Compare Interpharm Holdings Inc. job title salaries vs competitors

Company	Highest salary	Hourly salary
Interpharm Holdings Inc.	$59,807	$28.75
Pernix Therapeutics Holdings	$83,788	$40.28
Cambridge Major Laboratories, Inc.	$76,348	$36.71
Nostrum Laboratories	$63,418	$30.49
Hi-Tech Pharmacal	$62,012	$29.81
Tergus Pharma	$61,740	$29.68
Pharmaceutics International	$61,261	$29.45
URL Pharma	$61,097	$29.37
Novel Laboratories	$61,022	$29.34
Andrx Corp	$60,856	$29.26
Collegium Pharmaceutical	$60,273	$28.98
Contract Pharmacal	$60,024	$28.86
STASON PHARMACEUTICALS	$59,872	$28.78
Mayne Pharma	$59,766	$28.73
Irvine Pharmaceutical Services	$59,337	$28.53
Mikart	$59,251	$28.49
Upm Pharmaceuticals, Inc.	$59,100	$28.41
LLS Health CDMO	$59,040	$28.38
Sovereign Pharmaceuticals	$59,016	$28.37
Eon Labs, Inc.	$58,988	$28.36

Do you work at Interpharm Holdings Inc.?

Is Interpharm Holdings Inc. able to compete effectively with similar companies?

Interpharm Holdings Inc. jobs

Interpharm Holdings Inc. demographics vs competitors

Compare gender at Interpharm Holdings Inc. vs competitors

Job title	Male	Female
Tergus Pharma	44%	56%
Mikart	51%	49%
Mayne Pharma	59%	41%
Pharmaceutics International	60%	40%
Collegium Pharmaceutical	64%	36%
Interpharm Holdings Inc.	-	-

Male

Female

100%

75%

50%

25%

Interpharm Holdings Inc.

Collegium Pharmaceutical

Pharmaceutics International

Mayne Pharma

Mikart

Tergus Pharma

25%

50%

75%

100%

Compare race at Interpharm Holdings Inc. vs competitors

Company	White	Hispanic or Latino	Black or African American	Asian	Unknown	Diversity score
Collegium Pharmaceutical	61%	22%	6%	8%	3%	7.4
Pharmaceutics International	38%	9%	17%	24%	13%	9.4
Mayne Pharma	50%	33%	8%	5%	3%	7.2
Mikart	50%	16%	22%	9%	3%	8.1
Tergus Pharma	53%	6%	15%	22%	4%	7.4

Interpharm Holdings Inc. and similar companies CEOs

CEOBio

Joseph J. Ciaffoni

Collegium Pharmaceutical

Joe Ciaffoni was appointed President and Chief Executive Officer of Collegium Pharmaceutical in July 2018. Joe Ciaffoni joined Collegium Pharmaceutical in May 2017 as Executive Vice President and Chief Operating Officer. Prior to joining Collegium, he served as President, U.S. Branded Pharmaceuticals of Endo International plc. Before that, Joe Ciaffoni held various positions of increasing responsibility at Biogen, including Senior Vice President, Global Specialty Medicines Group, Senior Vice President, U.S. Commercial and Vice President, U.S. Neurology Field Operations and Marketing. Prior to joining Biogen, he was Executive Vice President and Chief Operating Officer of Shionogi Inc. and President of Shionogi Pharmaceuticals. Joe Ciaffoni also previously served as Vice President, Sales for Schering-Plough (now Merck) and held several commercial leadership roles at Sanofi-Synthelabo (now Sanofi) and Novartis. Joe Ciaffoni received a B.A. in Communications and an M.B.A. from Rutgers.

John A. Sedor

Pernix Therapeutics Holdings

An intuitive leader who engenders a deep level of trust and loyalty while providing a clear vision and business strategy, with a proven track record in the pharmaceutical, generic, biotechnology and consumer product industries. Recognized for entrepreneurial leadership approach to turnaround and rapid growth environments, leveraging strategic creativity, consumer and professional customer insight, merger and acquisition experience and operational expertise, all driving shareholder value. Open to contract C-level and Board of Director positions.

Matthew Wolf

Contract Pharmacal

David Seltzer

Hi-Tech Pharmacal

David Seltzer is a Chairman/Pres/CEO/Treasurer at HI TECH PHARMACAL CO INC, Board Member at NovelStem International Corp, and Owner at Leading Pharma. He has experience at Bergen Brunswig Corp and AMERISOURCEBERGEN CORP and has worked as Exec VP:Admin/Treasurer/Secy at HI TECH PHARMACAL CO INC, Treasurer/Secretary at HI TECH PHARMACAL CO INC, and VP:Admin/COO/Treasurer/Secy at HI TECH PHARMACAL CO INC. David attended Queens University of Charlotte.

Mark Mitchnick

LLS Health CDMO

John Fowler

Pharmaceutics International

Scott Richards

Mayne Pharma

John M. Gregory

Upm Pharmaceuticals, Inc.

Michael Kallelis

Mikart

An entrepreneurial executive specializing in growth strategies. Managing, motivating and coaching people toward a common business goal is a core strength. Experience includes Board of Directors, IPO, M&A, Sales, Business Development, Marketing and Operations. Expertise in start-ups to Fortune 6 environments.Applied growth strategies within the following market segments:In Vitro Diagnostics, Instrument Development, Single-Use bioreactors, Gene Expression Analysis, GMP services, Filtration, Cell Culture, Microscopy, Protein Crystallography, Liquid Chromatography, DNA/RNA chemistry, Peptide chemistry, Biologics, Biosimilars and Drug Development.

Stephan Kutzer

Cambridge Major Laboratories, Inc.

Stephan Kutzer is a Chief Executive Officer at aaiPharma Inc and Chief Executive Officer at Cambridge Major Laboratories Inc. He has worked as COO:Pharma & Biotech Mkt Segment at Lonza America Inc., Head:Performance Chemicals at Lonza America Inc., and Site Manager:Bayport at Lonza America Inc.. Stephan studied at Technische Universitaet Muenchen.